302 related articles for article (PubMed ID: 32030570)
1. Management of brain metastases in breast cancer: a review of current practices and emerging treatments.
Mills MN; Figura NB; Arrington JA; Yu HM; Etame AB; Vogelbaum MA; Soliman H; Czerniecki BJ; Forsyth PA; Han HS; Ahmed KA
Breast Cancer Res Treat; 2020 Apr; 180(2):279-300. PubMed ID: 32030570
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
Fares J; Kanojia D; Rashidi A; Ahmed AU; Balyasnikova IV; Lesniak MS
Clin Breast Cancer; 2019 Dec; 19(6):383-391. PubMed ID: 31262686
[TBL] [Abstract][Full Text] [Related]
3. Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Mills MN; King W; Soyano A; Pina Y; Czerniecki BJ; Forsyth PA; Soliman H; Han HS; Ahmed KA
J Neurooncol; 2022 Apr; 157(2):249-269. PubMed ID: 35244835
[TBL] [Abstract][Full Text] [Related]
4. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
5. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Schlam I; Gatti-Mays ME
Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
8. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
9. New insights and emerging therapies for breast cancer brain metastases.
Lim E; Lin NU
Oncology (Williston Park); 2012 Jul; 26(7):652-9, 663. PubMed ID: 22888567
[TBL] [Abstract][Full Text] [Related]
10. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Van Swearingen AED; Siegel MB; Deal AM; Sambade MJ; Hoyle A; Hayes DN; Jo H; Little P; Dees EC; Muss H; Jolly T; Zagar TM; Patel N; Miller CR; Parker JS; Smith JK; Fisher J; Shah N; Nabell L; Nanda R; Dillon P; Abramson V; Carey LA; Anders CK
Breast Cancer Res Treat; 2018 Oct; 171(3):637-648. PubMed ID: 29938395
[TBL] [Abstract][Full Text] [Related]
11. Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients.
Puri S; Chaudhry A; Bayable A; Ganesh A; Daher A; Gadi VK; Maraka S
Curr Oncol Rep; 2023 Dec; 25(12):1419-1430. PubMed ID: 37924439
[TBL] [Abstract][Full Text] [Related]
12. Management of breast cancer brain metastases.
Takahashi H; Isogawa M
Chin Clin Oncol; 2018 Jun; 7(3):30. PubMed ID: 30056732
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.
Wang Y; Ye F; Liang Y; Yang Q
Br J Cancer; 2021 Oct; 125(8):1056-1067. PubMed ID: 34226684
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer brain metastases: Molecular subtype, treatment and survival.
Crozier JA; Cornell LF; Rawal B; Perez EA
Breast Dis; 2016; 36(4):133-141. PubMed ID: 27802190
[TBL] [Abstract][Full Text] [Related]
15. Brain metastases in breast cancer.
Sim HW; Morris PG; Patil S; Khasraw M
Expert Rev Anticancer Ther; 2014 Feb; 14(2):173-83. PubMed ID: 24308683
[TBL] [Abstract][Full Text] [Related]
16. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain.
Krishnan M; Krishnamurthy J; Shonka N
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469897
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary management of brain metastases.
Eichler AF; Loeffler JS
Oncologist; 2007 Jul; 12(7):884-98. PubMed ID: 17673619
[TBL] [Abstract][Full Text] [Related]
19. Targeted and immunotherapeutic approaches in brain metastases.
Ahluwalia MS; Winkler F
Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies for breast cancer brain metastases.
Bailleux C; Eberst L; Bachelot T
Br J Cancer; 2021 Jan; 124(1):142-155. PubMed ID: 33250512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
